21,255
Total Claims
$2.6M
Drug Cost
4,608
Beneficiaries
$559
Cost/Patient
Peer Comparison vs. 21,761 Pharmacist providers
+14%
Cost per patient vs peers
$559 vs $489 avg
-83%
Brand preference vs peers
15.5% vs 91.9% avg
Brand vs Generic
85% generic
Brand: 3,240 claims · $2.2M
Generic: 17,626 claims · $329K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 249 | $353K |
| Empagliflozin | 264 | $316K |
| Insulin Glargine,hum.Rec.Anlog | 214 | $175K |
| Liraglutide | 81 | $138K |
| Semaglutide | 97 | $126K |
| Insulin Aspart | 86 | $96K |
| Sitagliptin Phosphate | 98 | $93K |
| Insulin Glargine,hum.Rec.Anlog | 155 | $91K |
| Budesonide/Formoterol Fumarate | 149 | $81K |
| Tirzepatide | 41 | $49K |
| Insulin Lispro | 50 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $42K |
| Insulin Degludec | 29 | $36K |
| Tiotropium Bromide | 44 | $36K |
| Insulin Aspart | 26 | $34K |
Prescribing Profile
Patient Profile
71
Avg Age
62%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About